This website runs on green hosting - verified by thegreenwebfoundation.org

SRF Limited Delivers Strong Growth in Q2 & H1 FY26

Oct 27, 2025 | News

Gurugram, October 27, 2025: SRF Limited, a chemical based multi-business entity engaged in the manufacturing of industrial and specialty intermediates today announced its consolidated financial results for the second quarter and half year ended September 30, 2025. The company’s unaudited results were approved by the Board of Directors in a meeting held earlier today.  

Consolidated Q2FY26 Financials

The consolidated revenue of the company increased 6% from ₹3,424 crore to ₹3,640 crore in Q2FY26 when compared with Corresponding Period Last Year (CPLY). The company’s Earnings before Interest and Tax (EBIT) increased 56% from ₹417 crore to ₹650 crore in Q2FY26 when compared with CPLY. The company’s Profit after Tax (PAT) increased 93% from ₹201 crore to ₹388 crore in Q2FY26 when compared with CPLY. Commenting on the results, Chairman and Managing Director, Ashish Bharat Ram said, “We performed well this quarter, led by our Chemicals Business. While we are dealing with a very uncertain global environment, we remain confident of a good finish to the year”.  

Consolidated Q2FY26 Segment Results

The Chemicals Business reported a 23% increase in segment revenue, from ₹1,358 crore to ₹1,667 crore during Q2FY26 compared to CPLY. Operating profit rose by 96%, from ₹246 crore to ₹481 crore in the same period. The Fluorochemicals Business reported record sales volumes for refrigerants, with prices of key refrigerants witnessing positive traction. During the quarter, the Business entered a strategic collaboration with The Chemours Company regarding certain fluoropolymers, which is expected to contribute to future growth. The Specialty Chemicals Business reported increased volumes for some of its products, while the introduction of new products also generated positive momentum. Operational efficiency measures were implemented, in both the Fluorochemicals and Specialty Chemicals Business segments, which contributed to an expanded margin profile. The Performance Films & Foil Business experienced a marginal decline in segment revenue, decreasing from ₹1,421 crore to ₹1,408 crore during Q2FY26 compared to CPLY. Operating profit, however, recorded a significant increase of 44%, rising from ₹83 crore to ₹119 crore in Q2FY26 over CPLY. During Q2FY26, the Performance Films and Foil Business achieved margin growth in its value-added product segment. The Business also maintained its status as the leading exporter of BOPET films in India. As a result of GST reforms implemented this quarter, the market experienced reduced volumes attributable to resizing and reprinting activities. These adjustments are expected to yield positive outcomes in the near future. The Technical Textiles Business reported a decrease of 11% in its segment revenue from ₹536 crore to ₹474 crore during Q2FY26 over CPLY. The operating profit of the Technical Textiles Business decreased 41% from ₹71 crore to ₹42 crore in Q2FY26 over CPLY. During the quarter, the Technical Textiles Business faced significant headwinds due to aggressive import pricing of Nylon Tyre Cord Fabrics and Belting Fabrics from China and low demand for Polyester Industrial Yarn. The Other Businesses reported a decrease of 19% in its segment revenue from ₹113 crore to ₹91 crore in Q2FY26 when compared with CPLY. The operating profit of the Other Businesses decreased 56% from ₹17 crore to ₹8 crore in Q2FY26 over CPLY. During the quarter, the Coated and Laminated Fabrics segments reported lower performance due to certain prevailing market conditions.  

H1 FY26 Financials

In the first six months of FY26, SRF’s revenue increased 8% from ₹6,888 crore to ₹7,459 crore over CPLY. The company’s PAT increased 81% from ₹454 crore to ₹820 crore over CPLY.  

Capex

In line with SRF’s strategic collaboration with The Chemours Company for manufacture and supply of fluoropolymers and fluoroelastomers, and in response to subsequent revisions in project scope, the Board has revised the previously sanctioned capital expenditure from ₹595 crore to ₹745 crore. The project is expected to be completed in a sequential manner, with the final phase scheduled for completion by December 2026.  

Key Personnel Announcement

As of September 30, 2025, the company has applied for a total of five hundred and one patents. Till date, the company has been granted one hundred and fifty-three patents globally.  

Awards and Recognition

SRF was named ‘Supply Chain Planning Champion’ and ‘Supply Chain Champion – Diversified Sector’ in the ISCM Supply Chain Ranking 2025.
Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026
Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026

Aug 19, 2025

Gurugram, India / Wilmington, Del., August 19, 2025: – The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market posi...

SRF Limited Posts Impressive Q1FY26 Results, Driven by Chemicals Business Momentum
SRF Limited Posts Impressive Q1FY26 Results, Driven by Chemicals Business Momentum

Jul 23, 2025

Gurugram, July 23, 2025: SRF Limited, a chemical-based multi-business entity engaged in the manufacturing of industrial and specialty intermediates, t...

SRF Limited Reports 21% Revenue Growth, 60% PBT Increase in Q4FY25
SRF Limited Reports 21% Revenue Growth, 60% PBT Increase in Q4FY25

May 12, 2025

Gurugram, May 12, 2025: SRF Limited, a chemical based multi-business entity engaged in the manufacturing of industrial and specialty intermediates tod...

NSE

NSE: SRF

2,853.50

36.40 (1.26%)

BSE

BOM: 503806

2,852.40

35.65 (1.23%)

Go to Top